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Abstract The homeodomain protein, Cdx2, has been implicated
in the transcriptional regulation of genes expressed in the small
intestine. In vitro studies of the carbonic anhydrase 1 (CA1)
colon promoter implied that Cdx2 may also play a role in the
regulation of colon-specific gene expression. The current work
follows up this proposal by examining the ability of Cdx2 to
transactivate gene expression in cultured cells mediated by CA1
promoter sequences. The results show that Cdx2 exerts a positive
regulatory effect by binding to a motif 87 bp upstream of the
CA1 TATA box; this motif appears to act as an enhancer since
gene activation is independent of its orientation.
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1. Introduction
Carbonic anhydrase (CA) is located in the cytoplasm and
apical cell membrane of colon epithelial cells. The colon epi-
thelium conducts the absorption and secretion of ions and
water via its extensive and accessible cellular surface. The
function of CA in the colon is principally that of electroneu-
tral sodium chloride reabsorption and short chain fatty acid
(SCFA) uptake [1,2]. CA catalyses the hydration of CO2 to
form HCO33 and H
 ions which are subsequently exported
from the cell in exchange with Na and Cl3 ions [1]. The
secretion of HCO33 is also important for alkalinisation of
the luminal contents thereby maintaining a favourable pH
for bacterial £ora, and for active exchange for SCFAs [2].
H ions secreted into the lumen of the colon are also involved
in the passive, non-ionic, di¡usive uptake of SCFAs [3].
Three carbonic anhydrase genes are expressed in the colon,
CA1, CA2 and CA4 [4^7]. CA1 and CA2 proteins are found
in the cytoplasm of epithelial cells, while CA4 is membrane-
bound. CA2 and CA4 are found throughout the length of the
gastrointestinal tract whereas CA1 is speci¢cally expressed at
high levels in the colon [8,9].
The CA1 gene is unusual amongst the carbonic anhydrases
in having two cell-type-speci¢c promoters which act in a mu-
tually exclusive manner. The proximal promoter transcribes
CA1 in colon epithelia, while the more distal promoter is
active in erythroid cells [9,10]. While the regulation of the
CA1 gene in erythroid cells has been well characterised
[10,11], the factors which control the expression of the CA1
gene in intestinal cells are not known.
Our earlier studies using electrophoretic mobility shift as-
says (EMSA) identi¢ed a region within the proximal colon
promoter of the human CA1 gene which binds a factor
present only in colon cells [12]. Sequence comparisons showed
that the DNA motif binding this factor was similar to an
element in the promoter of the small intestinal gene, su-
crase-isomaltase (SI), which binds the homeodomain protein,
Cdx2 [13]. Cdx2 has been shown thus far to activate the ex-
pression of a number of small intestine genes [13^15],
although Cdx2 is abundant both in the small intestine and
colon [16,17]. In the present study we have sought to con¢rm
that Cdx2 is interacting with the CA1 colon promoter sequen-
ces in a biological system, and in a manner which leads to
either activation or repression of gene transcription. This
question was examined directly by co-transfection of recombi-
nant mouse Cdx2 together with DNA constructs comprising a
minimal promoter downstream of various CA1 sequences,
into cells which normally do not express either CA1 or Cdx2.
2. Materials and methods
2.1. Preparation of CA1 promoter/reporter gene constructs
Regions of the human CA1 colon promoter (Fig. 1) were cloned
into the pCAT3-promoter vector (pSV40/CAT, Promega) upstream of
the SV40 early promoter. These included a double-stranded 17 bp
oligonucleotide 3118 bp to 3102 bp of the CA1 promoter encom-
passing the core motif -TTTTACAA- (CPO17); an 89 bp PCR frag-
ment 3147 bp to 359 bp (CP1) extending across the same motif (Fig.
1) and a 166 bp PCR fragment comprising 3224 bp to 359 bp
(designated CP1/2) containing the CPO17 motif and a second putative
Cdx2 binding element (Fig. 1). The antisense CPO17 oligonucleotide
was given ends compatible with SacI and XhoI overhangs, to allow
directional cloning into pSV40/CAT. The CP1 and CP1/2 PCR frag-
ments were inserted, in their natural and reverse orientations by TA-
cloning into T-tailed SmaI-cut pSV40/CAT. Diagnostic digests were
performed to con¢rm the identity and orientations of the inserts.
Constructs were sequenced using an ALFexpress automated DNA
sequencer (Pharmacia). For high levels of Cdx2 expression, the plas-
mid pRc/CMV-Cdx2 (pCdx2) containing the Cdx2 cDNA down-
stream of a CMV promoter was used.
2.2. Transfection studies
HeLa cells for transfection experiments were cultured to 60^70%
con£uence, as previously described [12]. Cells were seeded at 5U105
cells in 60 mm dishes 24 h prior to transfection. 5 Wg of each CA1
reporter construct was co-transfected with either 5 Wg of pCdx2 or
5 Wg of pSV-L-Gal. Transfections were carried out using the calcium
phosphate (CaPO4) procedure exactly as described [18] except that
cells were incubated for 20 h with the CaPO4/DNA precipitate, prior
to washing and further culture for 28 h. Transfections were tested in
two identical dishes of cells and each experiment was repeated at least
three times (in some cases 10 times, all in duplicate). CAT activity was
monitored by two methods, thin layer chromatography (TLC) and
liquid scintillation counting (LSC). Cell extracts were heat treated at
60‡C for 10 min prior to assaying. Plasmids used as controls in trans-
fection experiments included pSV40/CAT to estimate basal levels of
CAT expression and pCAT control (Promega) to provide high levels
of CAT expression. Puri¢ed CAT enzyme (Boehringer) was also used
as a control in TLC assays.
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2.3. TLC assays
For TLC assays 100 Wl of cell lysate was mixed with 3 Wl of
[14C]chloramphenicol (0.15 WCi) and 5 Wl of n-butyryl CoA, the vol-
ume adjusted to 125 Wl with distilled water and incubated at 37‡C for
3 h. Samples were extracted with 500 Wl ethyl acetate; the organic
phase was dried and resuspended in 20 Wl of ethyl acetate for spotting
onto TLC plates (Merck). Unmodi¢ed substrate and C1- and C3-
butyrylated chloramphenicol were resolved by TLC in 250 ml of
chloroform:methanol (97:3) at room temperature for 1 h. Plates
were air-dried and autoradiographed with Kodak X-ray ¢lm.
2.4. LSC assays
For LSC assays sample reactions were carried out as for TLC
assays except that butyrylated products were extracted with 300 Wl
of xylene. The organic phase was further extracted with 100 Wl of
0.25 M Tris-HCl and 150 Wl of the organic phase added directly to
1 ml of liquid scintillant and counted in an LKB 1211 minibeta scin-
tillation counter. The value obtained for untransfected HeLa cells was
deducted from that obtained for transfected cells. Duplicate estimates
were averaged and expressed as a percentage of those obtained with
the pCAT control vector transfected in the same experiment.
2.5. Electrophoretic mobility shift assays
Preparation of whole cell extracts from the colon carcinoma cell
line HT115, labelling of double-stranded oligonucleotides and EMSAs
were carried out as described previously [12]. Competitor oligo-
nucleotide was added to the DNA/protein binding mix prior to in-
cubation.
3. Results
3.1. Analysis of gene activation mediated by Cdx2 and CA1
promoter sequences
Our earlier DNase I hypersensitive site mapping and
EMSAs identi¢ed an element in the CA1 promoter which
binds a protein found only in cells derived from the colon
(shown as COF1/1P in Fig. 6A) [12]. The protein binding
element was contained within an 89 bp stretch of sequence
(3147 to 359 bp, designated CP1) (Fig. 1); after making
various deletions of this sequence it was found that binding
activity was retained by a 17 bp sequence (3118 to 3102 bp,
designated CPO17). Sequence comparisons showed that the
core sequence of this motif, -TTTTACAA-, was similar to
elements found in the promoters of the small intestinal genes,
SI and lactase (LPH) which are known to bind the homeo-
domain protein, Cdx2 [13,15].
Since Cdx2 is expressed both in small intestine and colon it
seems reasonable to infer that this transcription factor also
plays a role in the regulation of genes in the colon in vivo.
We have investigated this possibility by assessing whether
Cdx2 can modify gene transcription in cultured cells, by in-
teraction with CA1 sequence motifs. Transient transfection
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Fig. 1. Sequence of the human proximal CA1 colon promoter. The 359 to 3147 bp fragment (CP1) is indicated by underlining and the 3122
to 3224 bp fragment (CP2) by overlining. The transcription start site +1 is indicated (angled arrow). Asterisks indicate the position of two po-
tential Cdx2 binding sites and the TATA box.
Fig. 2. TLC assay of duplicate transfections of HeLa cells with CA1/SV40/CAT constructs in the presence (+) or absence (3) of pCdx2. The
position of each CA1 promoter fragment relative to the transcription start site is indicated and those in reverse orientation are shown as R. C1
and C3 indicate the butyrylated products of chloramphenicol; nonBut indicates unmodi¢ed substrate.
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assays were performed using various fragments of CA1 pro-
moter sequence (but excluding the TATA box), attached to an
SV40 minimal promoter and upstream of the CAT reporter
gene. HeLa cells were chosen because they do not normally
express either CDX2 (or CA1) and complications due to the
presence of endogenous gene activity are not an issue.
Changes in the level of CAT gene transcription were judged
from measurements of CAT enzyme activity using thin layer
chromatography (for examples see Figs. 2 and 3) and liquid
scintillation counting (data summarised in Fig. 4).
The CA1 DNA promoter fragments contained in the con-
structs used in these studies were as follows: 3118 bp to 3102
bp of the CA1 promoter encompassing the single copy of the
core motif -TTTTACAA- (CPO17); 3147 bp to 359 bp
(CP1), which contains this motif and 80 bp of additional
sequence; and 3224 bp to 359 bp (designated CP1/2) which
also contains further 5P sequences including a second copy of
the core motif -TTTTACAA-, identi¢ed 54 bp upstream (Fig.
1). Co-transfection with a Cdx2 expression vector led to an
increase in CAT gene activity by all constructs (Figs. 2 and 3).
Overall, the highest level of activity, 64% of the pCAT-control
vector, was found for the shortest fragment, 3118 bp to 3102
bp. In general the constructs containing longer CA1 promoter
elements showed relatively lower levels of gene activation,
36% and 44% activity were found for the 3147 bp to 359
bp (CP1-CAT) and 3224 bp to 359 bp (CP1/2-CAT) respec-
tively (Figs. 2^4). The reason for this is not clear but may
re£ect some interaction between the CA1 sequences and other
factors in the HeLa cell extracts which interfere with tran-
scription of the reporter gene. Interestingly the 3147 bp to
359 bp and 3224 bp to 359 bp fragments of CA1 promoter
sequence showed 41% and 39% of pCAT-control activity re-
spectively, when placed in a reverse direction relative to the
SV40 promoter (Figs. 2^4). In Fig. 4, the di¡erences between
the means, with and without pCdx2, were tested for signi¢-
cance using Student’s t-test, and in all cases the increase in
CAT activity was statistically signi¢cant except for the pCP1-
CAT which was borderline, P = 0.1.
In the SI gene two copies of the Cdx2 binding motif occur
as an inverted repeat [13]; in the lactase gene only a single
copy is found [15]. Suh and colleagues [13] have shown that
mutation of the central core of the SI binding site, GCAA-
TAAAACTTTATGA to GCAAGCCAACGGGATGA abol-
ishes gene activation by the SI promoter. In order to con¢rm
the importance of the CA1 promoter motif in Cdx2 binding,
the binding site (-AATTTTTTACAACACCT-) was mutated
to change the central core from -TTTTACA- to -TTTGCCA-
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Fig. 3. TLC assay after duplicate transfections of HeLa cells with
constructs containing CA1 3118 bp to 3102 bp (CPO17) and its
mutated version (mut17), in the presence (+) or absence (3) of
pCdx2, or with the positive control plasmid, pCAT control. Un-
transfected cells are also shown. C1 and C3 indicate the butyrylated
products of chloramphenicol; nonBut indicates unmodi¢ed sub-
strate.
Fig. 4. CAT assays after transient transfection of CA1/SV40/CAT constructs in HeLa cells. [14C]Butyrylated chloramphenicol was assayed by
liquid scintillation counting in duplicate and the results from three to ten experiments were pooled and averaged. The constructs are shown to
the left; the position of each CA1 promoter fragment relative to the transcription start site is indicated. Those fragments in reverse orientation
are indicated as R. Constructs were transfected alone (solid bars), or together with pCdx2 (open bars). Results for each construct are expressed
as a percentage of the pCAT control activity þ S.D.
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(Figs. 3 and 6B). The ability of this construct to mediate gene
activation was much reduced such that CAT activity was only
5% of pCAT control in the presence of Cdx2, re£ecting a
marked decrease in the ability to bind Cdx2 at the mutated
sequence (Figs. 3 and 4).
Several observations can be made from these results ; Cdx2
appears to exert a positive regulatory e¡ect by binding to a
CA1 sequence element, -AATTTTTTACAACACCT-; the
CA1 sequence element appears to act as an enhancer element
since gene activation induced by Cdx2 is independent of the
orientation of the CA1 binding motif ; and the presence of two
copies of the Cdx2 binding motif (as in the 3224 bp to 359
bp construct) does not increase gene activity above that seen
in the presence of a single copy of the core motif -TTTTACA-
alone.
3.2. Activation of the SV40 minimal promoter by Cdx2
The estimates of relative CAT gene activity summarised in
Fig. 4 were made after deduction of background activities due
to the SV40 minimal promoter, which were assessed sepa-
rately for each set of transfections. It was noted, incidentally,
that transcription from the SV40 minimal promoter alone was
increased to a low, but signi¢cant level (16% of pCAT con-
trol) in the presence of Cdx2 (Fig. 5). We considered the
possibility that this activation was due to Cdx2 binding to a
motif within the SV40 minimal promoter. Sequence compar-
isons pointed to the SV40 TATA box, which has the core
sequence -TTTATG-, identical to the core Cdx2 binding motif
in the SI gene promoter [13] and indeed an oligonucleotide
encompassing the SV40 TATA box when used as competitor
in competitive binding assays, partially competed for the bind-
ing of Cdx2 to the CA1 3118 bp to 3102 bp (CPO17) ele-
ment (Fig. 6A). This ¢nding is similar to that of Lambert and
colleagues [19] who demonstrated Cdx2 binding to the TATA
box of the rat calbindin-D9k (CaBP9k) gene, and raises the
possibility that Cdx2 might perhaps bind to the TATA box of
the human CA1 gene itself. Both CA1 and human CaBP9k
TATA box motifs were tested in competition assays and both
partially competed for the binding of the CA1 3118 bp to
3102 bp (CPO17) element, but the CA1 TATA motif, in
particular, competed much less e⁄ciently than the CA1
3118 bp to 3102 bp (CPO17) element (Fig. 6A).
4. Discussion
Evidence from the studies presented here, taken together
with our earlier EMSA and supershift assays [12], leads to
the conclusion that the homeodomain transcription factor,
Cdx2, is important in the regulation of colon-speci¢c carbonic
anhydrase 1 (CA1). The distributions of colon CA1 and Cdx2
are consistent with a role for Cdx2 in the regulation of CA1 in
vivo, since both are con¢ned to the intestine epithelium and
are most abundant in proximal colon; however, CA1 expres-
sion is limited to the colon (large intestine) whereas Cdx2 is
also expressed in the small intestine [8,16]. Cdx2 has recently
been recognised as an important transcription factor in the
regulation of a number of genes expressed in the small intes-
tine ^ sucrase-isomaltase (SI) [13], lactase-phlorizin hydrolase
(LPH) [15], intestinal phospholipase A/lysophospholipase
(IPAL) [14], calbindin 9K (CaBP9k) [19] ^ and pancreatic islet
cell expressed genes ^ proglucagon [20] and insulin [21]. Fur-
thermore Cdx2 has been shown to induce morphological and
molecular di¡erentiation in undi¡erentiated intestinal cell
lines [22]. Recently Taylor and colleagues [23] have demon-
strated that Cdx2 is able to activate transcription from the SI
promoter and from heterologous promoters when the SI Cdx2
binding element is placed in an enhancer context. Our ¢nding
that gene activation mediated by a Cdx2 binding element in
the CA1 promoter is orientation independent is in line with
this observation.
It is relevant to note that the Cdx2 null heterozygote mouse
is characterised by the presence of multiple colonic tumours
which occur most frequently in the proximal portion of the
colon [24] where CA1 is most abundant [6]. As yet there is no
information regarding expression of CA1 in these mice but
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Fig. 5. LSC assays showing CAT gene activation mediated by Cdx2 binding to the SV40 minimal promoter.
Fig. 6. A: EMSA using labelled CA1 3118 bp to 3102 bp
(CPO17) as probe and HT115 protein extracts. Each competitor oli-
gonucleotide was at 100-fold molar excess of the probe. Comp =
competitor; 3= no competitor. 9k = CaBP9k TATA; SV40 = SV40
TATA and CA1 = the CA1 TATA. COF1/COF1P are complexes
formed between the probe and the intestinal speci¢c factor, Cdx2.
B: Oligonucleotides used in the EMSA shown above.
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there are several reports which show that in human colon
carcinomas, CA1 is markedly down-regulated [9,25].
The mechanism whereby CA1 transcription is suppressed in
the small intestine remains to be identi¢ed, but the presence of
other regulatory sequences is indicated by the mapping of
upstream DNase I hypersensitive sites as well as conserved
protein binding DNA sequence motifs in the CA1 colon pro-
moter [12,26]. For example, conserved binding elements for
the GATA family of transcription factors and hepatocyte nu-
clear factors (HNF-1) occur within the proximal promoter
[26]; in other genes, such as epsilon-globin [27], serine dehy-
dratase [28] and apolipoprotein B [29] such elements are
known to function as negative cis-acting elements.
The possibility that Cdx2 can in£uence transcription by
binding to the TATA box motif of the CA1 gene promoter
requires further investigation. This may be of signi¢cance
since binding of Cdx2 to a TATA box motif in an intestinal
gene promoter, calbindin 9K (CaBP9k) has been described
and led to the proposal that Cdx2 might interact with other
factors speci¢c to intestinal cells to regulate intestine-speci¢c
expression via the TATA box [19].
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